Disitertide

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDisitertide
Drug Alias Name地司特肽disitertidum地西特肽disitertidedisitertida +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPolandItalyHungary +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDigna Biotech SlUniversity Of Navarra
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIsdinDigna Biotech Sl
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A